Efficacy and Safety of Shenfu Injection in Patients with Sepsis: a Real World Study

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200062321

Enrollment

Unknown

Registered

2022-08-01

Start date

2022-07-18

Completion date

Unknown

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

None:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.18 years and older 2.Diagnosed with Sepsis or Septic Shock by Sepsis 3.03.Patients was planed to use Shenfu injectionand TCM syndrome differentiation meets the instructions of Shenfu injection. It is used to mainly indicated for Yang Qi collapse syndromes caused by shock, and treat the following symptoms caused by Yang (Qi) deficiency, such as palpitation due to fright or palpitation with distress, dyspnea and cough, stomachache, diarrhea, arthralgia syndrome and so on; 4. Patients or family members agreed to participate in the study.

Exclusion criteria

Exclusion criteria: Pregnant and lying-in woman

Design outcomes

Primary

Measure	Time frame
ICU-stay/Hospital-stay;	—

Countries

China

Contacts

Public ContactYan Kang

West China Hospital,Sichuan University

kangyan@scu.edu.cn+86 18980601566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026